Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > The Ups and Downs of Nanobiotech

August 27th, 2004

The Ups and Downs of Nanobiotech

Abstract:
Ten years from now, a visit to the doctor could be quite different than it is today. How different? Imagine tiny particles that "cook " cancers from the inside out; "smart bomb" drugs that detonate only over their targets; and finely structured scaffolds that guide tissue regeneration. But it's not just imagination. In academic labs, small startups, and giant pharmaceutical companies, researchers in the blossoming field of nanotechnology have shown that these concepts can work -- at least in lab animals and tissue culture dishes. Now they are working to turn these proofs-of-principle into approved therapies. But a lot can happen between mouse and man, and many a "proven " therapy has failed to make the transition.

Source:
* The Scientist

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Preparing for Nano

Disruptive by Design: Nano Now February 1st, 2019

How nanoscience will improve our health and lives in the coming years: Targeted medicine deliveries and increased energy efficiency are just two of many ways October 26th, 2016

Searching for a nanotech self-organizing principle May 1st, 2016

Nanotechnology is changing everything from medicine to self-healing buildings: Nanotechnology is so small it's measured in billionths of metres, and it is revolutionising every aspect of our lives April 2nd, 2016

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project